Table: RaQualia Pharma -2020 group forecast
Feb 2 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2020 Dec 31, 2020
LATEST PREVIOUS
FORECAST FORECAST
Sales 1.11 852 mln
Operating loss 486 mln loss 753 mln
Recurring loss 527 mln loss 759 mln
Net loss 606 mln loss 843 mln
EPS loss 28.97 yen loss 40.24 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T